ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Publication Date: 2013-04-05
    Description: Membranes allow the compartmentalization of biochemical processes and are therefore fundamental to life. The conservation of the cellular membrane, combined with its accessibility to secreted proteins, has made it a common target of factors mediating antagonistic interactions between diverse organisms. Here we report the discovery of a diverse superfamily of bacterial phospholipase enzymes. Within this superfamily, we defined enzymes with phospholipase A1 and A2 activity, which are common in host-cell-targeting bacterial toxins and the venoms of certain insects and reptiles. However, we find that the fundamental role of the superfamily is to mediate antagonistic bacterial interactions as effectors of the type VI secretion system (T6SS) translocation apparatus; accordingly, we name these proteins type VI lipase effectors. Our analyses indicate that PldA of Pseudomonas aeruginosa, a eukaryotic-like phospholipase D, is a member of the type VI lipase effector superfamily and the founding substrate of the haemolysin co-regulated protein secretion island II T6SS (H2-T6SS). Although previous studies have specifically implicated PldA and the H2-T6SS in pathogenesis, we uncovered a specific role for the effector and its secretory machinery in intra- and interspecies bacterial interactions. Furthermore, we find that this effector achieves its antibacterial activity by degrading phosphatidylethanolamine, the major component of bacterial membranes. The surprising finding that virulence-associated phospholipases can serve as specific antibacterial effectors suggests that interbacterial interactions are a relevant factor driving the continuing evolution of pathogenesis.〈br /〉〈br /〉〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652678/" target="_blank"〉〈img src="https://static.pubmed.gov/portal/portal3rc.fcgi/4089621/img/3977009" border="0"〉〈/a〉   〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652678/" target="_blank"〉This paper as free author manuscript - peer-reviewed and accepted for publication〈/a〉〈br /〉〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Russell, Alistair B -- LeRoux, Michele -- Hathazi, Krisztina -- Agnello, Danielle M -- Ishikawa, Takahiko -- Wiggins, Paul A -- Wai, Sun Nyunt -- Mougous, Joseph D -- AI057141/AI/NIAID NIH HHS/ -- AI080609/AI/NIAID NIH HHS/ -- AI105268/AI/NIAID NIH HHS/ -- GM07270/GM/NIGMS NIH HHS/ -- R01 AI080609/AI/NIAID NIH HHS/ -- R21 AI105268/AI/NIAID NIH HHS/ -- U54 AI057141/AI/NIAID NIH HHS/ -- England -- Nature. 2013 Apr 25;496(7446):508-12. doi: 10.1038/nature12074. Epub 2013 Apr 3.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Microbiology, University of Washington, Seattle, Washington 98195, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/23552891" target="_blank"〉PubMed〈/a〉
    Keywords: Anti-Bacterial Agents/*metabolism ; *Antibiosis ; *Bacterial Secretion Systems ; Cell Membrane/chemistry/metabolism ; Evolution, Molecular ; Phosphatidylethanolamines/metabolism ; Phospholipase D/chemistry/classification/*metabolism ; Phylogeny ; Pseudomonas aeruginosa/*enzymology/metabolism/pathogenicity ; Species Specificity ; Substrate Specificity ; Virulence Factors/chemistry/metabolism
    Print ISSN: 0028-0836
    Electronic ISSN: 1476-4687
    Topics: Biology , Chemistry and Pharmacology , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 2
    Publication Date: 2011-07-22
    Description: Peptidoglycan is the major structural constituent of the bacterial cell wall, forming a meshwork outside the cytoplasmic membrane that maintains cell shape and prevents lysis. In Gram-negative bacteria, peptidoglycan is located in the periplasm, where it is protected from exogenous lytic enzymes by the outer membrane. Here we show that the type VI secretion system of Pseudomonas aeruginosa breaches this barrier to deliver two effector proteins, Tse1 and Tse3, to the periplasm of recipient cells. In this compartment, the effectors hydrolyse peptidoglycan, thereby providing a fitness advantage for P. aeruginosa cells in competition with other bacteria. To protect itself from lysis by Tse1 and Tse3, P. aeruginosa uses specific periplasmically localized immunity proteins. The requirement for these immunity proteins depends on intercellular self-intoxication through an active type VI secretion system, indicating a mechanism for export whereby effectors do not access donor cell periplasm in transit.〈br /〉〈br /〉〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146020/" target="_blank"〉〈img src="https://static.pubmed.gov/portal/portal3rc.fcgi/4089621/img/3977009" border="0"〉〈/a〉   〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146020/" target="_blank"〉This paper as free author manuscript - peer-reviewed and accepted for publication〈/a〉〈br /〉〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Russell, Alistair B -- Hood, Rachel D -- Bui, Nhat Khai -- LeRoux, Michele -- Vollmer, Waldemar -- Mougous, Joseph D -- R01 AI080609/AI/NIAID NIH HHS/ -- R01 AI080609-03/AI/NIAID NIH HHS/ -- England -- Nature. 2011 Jul 20;475(7356):343-7. doi: 10.1038/nature10244.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Microbiology, University of Washington, Seattle, Washington 98195, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/21776080" target="_blank"〉PubMed〈/a〉
    Keywords: Amidohydrolases/chemistry/genetics/metabolism ; Amino Acid Sequence ; Bacterial Proteins/antagonists & ; inhibitors/chemistry/genetics/*metabolism/secretion ; *Bacterial Secretion Systems ; Bacterial Toxins/antagonists & inhibitors/metabolism ; *Bacteriolysis ; Gram-Negative Bacteria/*cytology/*metabolism ; Hydrolysis ; *Microbial Interactions ; Muramidase/chemistry/genetics/metabolism ; Peptidoglycan/metabolism ; Periplasm/metabolism ; Pseudomonas aeruginosa/enzymology/genetics/growth & development/*metabolism ; Pseudomonas putida/growth & development/metabolism ; Substrate Specificity
    Print ISSN: 0028-0836
    Electronic ISSN: 1476-4687
    Topics: Biology , Chemistry and Pharmacology , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 3
    Publication Date: 2014-12-04
    Description: Horizontal gene transfer allows organisms to rapidly acquire adaptive traits. Although documented instances of horizontal gene transfer from bacteria to eukaryotes remain rare, bacteria represent a rich source of new functions potentially available for co-option. One benefit that genes of bacterial origin could provide to eukaryotes is the capacity to produce antibacterials, which have evolved in prokaryotes as the result of eons of interbacterial competition. The type VI secretion amidase effector (Tae) proteins are potent bacteriocidal enzymes that degrade the cell wall when delivered into competing bacterial cells by the type VI secretion system. Here we show that tae genes have been transferred to eukaryotes on at least six occasions, and that the resulting domesticated amidase effector (dae) genes have been preserved for hundreds of millions of years through purifying selection. We show that the dae genes acquired eukaryotic secretion signals, are expressed within recipient organisms, and encode active antibacterial toxins that possess substrate specificity matching extant Tae proteins of the same lineage. Finally, we show that a dae gene in the deer tick Ixodes scapularis limits proliferation of Borrelia burgdorferi, the aetiologic agent of Lyme disease. Our work demonstrates that a family of horizontally acquired toxins honed to mediate interbacterial antagonism confers previously undescribed antibacterial capacity to eukaryotes. We speculate that the selective pressure imposed by competition between bacteria has produced a reservoir of genes encoding diverse antimicrobial functions that are tailored for co-option by eukaryotic innate immune systems.〈br /〉〈br /〉〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713192/" target="_blank"〉〈img src="https://static.pubmed.gov/portal/portal3rc.fcgi/4089621/img/3977009" border="0"〉〈/a〉   〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713192/" target="_blank"〉This paper as free author manuscript - peer-reviewed and accepted for publication〈/a〉〈br /〉〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Chou, Seemay -- Daugherty, Matthew D -- Peterson, S Brook -- Biboy, Jacob -- Yang, Youyun -- Jutras, Brandon L -- Fritz-Laylin, Lillian K -- Ferrin, Michael A -- Harding, Brittany N -- Jacobs-Wagner, Christine -- Yang, X Frank -- Vollmer, Waldemar -- Malik, Harmit S -- Mougous, Joseph D -- AI080609/AI/NIAID NIH HHS/ -- AI083640/AI/NIAID NIH HHS/ -- BB/I020012/1/Biotechnology and Biological Sciences Research Council/United Kingdom -- R01 AI080609/AI/NIAID NIH HHS/ -- R01 AI083640/AI/NIAID NIH HHS/ -- Howard Hughes Medical Institute/ -- England -- Nature. 2015 Feb 5;518(7537):98-101. doi: 10.1038/nature13965. Epub 2014 Nov 24.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Microbiology, University of Washington School of Medicine, Seattle, Washington 98195, USA. ; 1] Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA [2] Howard Hughes Medical Institute, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. ; Centre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne NE2 4AX, UK. ; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. ; 1] Microbial Sciences Institute, Yale University, New Haven, Connecticut 06516, USA [2] Howard Hughes Medical Institute, Yale University, New Haven, Connecticut 06516, USA. ; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California 94158, USA. ; 1] Microbial Sciences Institute, Yale University, New Haven, Connecticut 06516, USA [2] Howard Hughes Medical Institute, Yale University, New Haven, Connecticut 06516, USA [3] Department of Microbial Pathogenesis, Yale University, New Haven, Connecticut 06516, USA [4] Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut 06516, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/25470067" target="_blank"〉PubMed〈/a〉
    Keywords: Amidohydrolases/genetics/metabolism/secretion ; Animals ; Bacteria/cytology/*enzymology/*genetics/immunology ; Bacterial Secretion Systems ; Bacterial Toxins/*genetics/metabolism ; Borrelia burgdorferi/cytology/growth & development/immunology ; Cell Wall/metabolism ; Conserved Sequence/genetics ; Eukaryota/*genetics/*immunology/metabolism ; Gene Transfer, Horizontal/*genetics ; Genes, Bacterial/*genetics ; *Immunity, Innate/genetics ; Ixodes/genetics/immunology/metabolism/microbiology ; Phylogeny ; Substrate Specificity
    Print ISSN: 0028-0836
    Electronic ISSN: 1476-4687
    Topics: Biology , Chemistry and Pharmacology , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...